Yüklüyor......

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

BACKGROUND: We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the addition of cetuximab to concurrent chemoradiation for patients with inoperable stage III non-small-cell lung cancer. METHODS: In this open-label randomis...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Lancet Oncol
Asıl Yazarlar: Bradley, Jeffrey D, Paulus, Rebecca, Komaki, Ritsuko, Masters, Gregory, Blumenschein, George, Schild, Steven, Bogart, Jeffrey, Hu, Chen, Forster, Kenneth, Magliocco, Anthony, Kavadi, Vivek, Garces, Yolanda I, Narayan, Samir, Iyengar, Puneeth, Robinson, Cliff, Wynn, Raymond B, Koprowski, Christopher, Meng, Joanne, Beitler, Jonathan, Gaur, Rakesh, Curran, Walter, Choy, Hak
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4419359/
https://ncbi.nlm.nih.gov/pubmed/25601342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)71207-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!